D E Jewitt, B N Singh. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralAdrenal Glands/physiologyAdrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/antagonists & inhibitorsAdrenergic beta-Antagonists/metabolismAdrenergic beta-Antagonists/pharmacologyAdrenergic beta-Antagonists/therapeutic useAlprenolol/pharmacologyAnimalsArrhythmias, Cardiac/etiologyAtrial Fibrillation/drug therapyAtrial Flutter/drug therapyBronchodilator Agents/adverse effectsHeart Block/etiologyHemodynamicsHumansInjections, IntravenousMyocardial Infarction/complicationsMyocardial Infarction/mortalityPractolol/metabolismPractolol/pharmacologyPropranolol/adverse effectsPropranolol/pharmacologyStructure-Activity RelationshipSympathetic Nervous System/physiologySympathomimetics/pharmacologyVentricular Fibrillation/drug therapy
Substances： See more » Adrenergic beta-AntagonistsBronchodilator AgentsSympathomimeticsAlprenololPropranololPractolol
Year: 1974 PMID： 4153071 DOI： 10.1016/0033-0620(74)90032-2
Source DB: PubMed Journal: Prog Cardiovasc Dis ISSN： 0033-0620 Impact factor: 8.194